Perbedaan Indosat Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Indosat Tbk. diperdagangkan di Rp1.885 (kapitalisasi pasar 61,12 T, volume 24 jam 16,17 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Indosat Tbk. jauh lebih besar — sekitar 365,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Indosat Tbk. lebih aktif diperdagangkan (16,17 jt vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ISAT | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 61,12 T | 167,37 M |
Volume | 16,17 jt | 96,7 rb |
Lot | 161,66 rb | 967 |
Perputaran | 30,64 M | 23,82 jt |
Harga Rata-rata | 1.895,38 | 246,34 |
Nilai Transaksi | 30,64 M | 23,82 jt |
Harga Ekuilibrium Indikatif | 1.885 | 248 |
Volume Ekuilibrium Indikatif | 18,21 rb | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.
Selengkapnya di halaman ISAT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →